ATE332703T1 - Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung - Google Patents
Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildungInfo
- Publication number
- ATE332703T1 ATE332703T1 AT04713307T AT04713307T ATE332703T1 AT E332703 T1 ATE332703 T1 AT E332703T1 AT 04713307 T AT04713307 T AT 04713307T AT 04713307 T AT04713307 T AT 04713307T AT E332703 T1 ATE332703 T1 AT E332703T1
- Authority
- AT
- Austria
- Prior art keywords
- wound healing
- hsp20
- promote wound
- reduce scaring
- scaring
- Prior art date
Links
- 230000029663 wound healing Effects 0.000 title abstract 2
- 102100039170 Heat shock protein beta-6 Human genes 0.000 title 1
- 101710100489 Heat shock protein beta-6 Proteins 0.000 title 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000036573 scar formation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44895403P | 2003-02-21 | 2003-02-21 | |
| US51221103P | 2003-10-17 | 2003-10-17 | |
| US53030603P | 2003-12-16 | 2003-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332703T1 true ATE332703T1 (de) | 2006-08-15 |
Family
ID=32931323
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06014290T ATE455553T1 (de) | 2003-02-21 | 2004-02-20 | Verwendung von hsp20 zur förderung der wundheilung und/oder zur reduzierung der narbenbildung |
| AT04713307T ATE332703T1 (de) | 2003-02-21 | 2004-02-20 | Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06014290T ATE455553T1 (de) | 2003-02-21 | 2004-02-20 | Verwendung von hsp20 zur förderung der wundheilung und/oder zur reduzierung der narbenbildung |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8101572B2 (de) |
| EP (2) | EP1594526B1 (de) |
| AT (2) | ATE455553T1 (de) |
| AU (1) | AU2004216241B2 (de) |
| DE (2) | DE602004025300D1 (de) |
| DK (2) | DK1808179T3 (de) |
| ES (2) | ES2268631T3 (de) |
| PT (1) | PT1808179E (de) |
| WO (1) | WO2004075914A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2268631T3 (es) | 2003-02-21 | 2007-03-16 | Arizona Board Of Regents | Utilizacion de hsp20 para estimular la cicatrizacion de heridas y/o para reducir la formacion de cicatrices. |
| AU2004281838B2 (en) | 2003-10-17 | 2008-01-31 | Arizona Board Of Regents | Novel heat shock protein 20-related polypeptides and uses therefor |
| JP5048772B2 (ja) * | 2006-07-12 | 2012-10-17 | ジ アリゾナ ボード オブ レジェンツ，ア ボディ コーポレイト アクティング フォア アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティ | 線維性疾患及びケロイドを治療及び抑制する方法 |
| DK2155228T3 (da) | 2007-01-10 | 2014-07-07 | Purdue Research Foundation | Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor |
| JP5703466B2 (ja) | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | キナーゼ阻害薬およびその使用 |
| AU2009324661A1 (en) | 2008-12-10 | 2011-07-07 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| WO2011017132A2 (en) | 2009-07-27 | 2011-02-10 | Purdue Research, Foundation | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
| WO2020167894A1 (en) * | 2019-02-12 | 2020-08-20 | Vanderbilt University | Polypeptides for restoring endothelial function and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280038A (en) | 1992-03-13 | 1994-01-18 | Virginia Commonwealth University | Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome |
| US5985635A (en) | 1996-11-15 | 1999-11-16 | Incyte Pharmaceuticals, Inc. | Nucleic acids encoding novel human serine/threonine protein kinases |
| US6475490B1 (en) | 1998-10-19 | 2002-11-05 | Fordham University | Compositions and methods for promoting tissue repair using heat shock proteins |
| US6812205B2 (en) | 2000-03-15 | 2004-11-02 | The Brigham & Women's Hospital, Inc. | Suppression of vascular disorders by mucosal administration of heat shock protein peptides |
| JP2001278894A (ja) | 2000-03-29 | 2001-10-10 | Osamu Ozawa | 血液循環障害予防および／または治療用医薬用組成物並びにその有効成分であるペプチド |
| EP1294871A1 (de) * | 2000-06-21 | 2003-03-26 | Amgen, Inc. | Sekretierte epithelial colon stromal-1 polypeptide, nukleinsäuren die für dieselben kodieren und verwendungen dafür |
| US7135453B2 (en) | 2001-08-23 | 2006-11-14 | Arizona Board Of Regents | Reagents and methods for smooth muscle therapies |
| WO2003084481A2 (en) | 2002-04-01 | 2003-10-16 | Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University | Biological affinity based delivery systems |
| AU2003269985A1 (en) | 2002-08-22 | 2004-03-11 | Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University, Office Of T | Methods for increasing the rate of heart muscle contraction |
| ES2268631T3 (es) | 2003-02-21 | 2007-03-16 | Arizona Board Of Regents | Utilizacion de hsp20 para estimular la cicatrizacion de heridas y/o para reducir la formacion de cicatrices. |
| AU2004281838B2 (en) | 2003-10-17 | 2008-01-31 | Arizona Board Of Regents | Novel heat shock protein 20-related polypeptides and uses therefor |
-
2004
- 2004-02-20 ES ES04713307T patent/ES2268631T3/es not_active Expired - Lifetime
- 2004-02-20 ES ES06014290T patent/ES2338350T3/es not_active Expired - Lifetime
- 2004-02-20 AU AU2004216241A patent/AU2004216241B2/en not_active Ceased
- 2004-02-20 EP EP04713307A patent/EP1594526B1/de not_active Expired - Lifetime
- 2004-02-20 DE DE602004025300T patent/DE602004025300D1/de not_active Expired - Lifetime
- 2004-02-20 DK DK06014290.8T patent/DK1808179T3/da active
- 2004-02-20 DK DK04713307T patent/DK1594526T3/da active
- 2004-02-20 WO PCT/US2004/004999 patent/WO2004075914A1/en not_active Ceased
- 2004-02-20 AT AT06014290T patent/ATE455553T1/de active
- 2004-02-20 US US10/545,518 patent/US8101572B2/en not_active Expired - Fee Related
- 2004-02-20 DE DE602004001509T patent/DE602004001509T2/de not_active Expired - Lifetime
- 2004-02-20 AT AT04713307T patent/ATE332703T1/de active
- 2004-02-20 PT PT06014290T patent/PT1808179E/pt unknown
- 2004-02-20 EP EP06014290A patent/EP1808179B1/de not_active Expired - Lifetime
-
2012
- 2012-01-04 US US13/343,127 patent/US8765673B2/en not_active Expired - Fee Related
-
2014
- 2014-05-21 US US14/284,210 patent/US20150072936A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1808179A3 (de) | 2007-10-24 |
| DE602004025300D1 (de) | 2010-03-11 |
| WO2004075914A1 (en) | 2004-09-10 |
| DK1808179T3 (da) | 2010-04-12 |
| US20150072936A1 (en) | 2015-03-12 |
| ATE455553T1 (de) | 2010-02-15 |
| EP1594526A1 (de) | 2005-11-16 |
| ES2268631T3 (es) | 2007-03-16 |
| PT1808179E (pt) | 2010-03-24 |
| AU2004216241B2 (en) | 2006-12-14 |
| EP1808179A2 (de) | 2007-07-18 |
| AU2004216241A1 (en) | 2004-09-10 |
| DE602004001509D1 (de) | 2006-08-24 |
| DE602004001509T2 (de) | 2007-02-15 |
| US8765673B2 (en) | 2014-07-01 |
| DK1594526T3 (da) | 2006-11-13 |
| US20100009903A1 (en) | 2010-01-14 |
| ES2338350T3 (es) | 2010-05-06 |
| US8101572B2 (en) | 2012-01-24 |
| EP1808179B1 (de) | 2010-01-20 |
| US20120238508A1 (en) | 2012-09-20 |
| EP1594526B1 (de) | 2006-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1615952T3 (da) | Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler | |
| IS8432A (is) | Mótefni sem bindast viðtaka hvítfrumuboða-4 | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| CY1119127T1 (el) | Επιτοποι σκληροστινης | |
| ATE454403T1 (de) | Menschliche koagulationsfaktor vii polypeptide | |
| DE602004017588D1 (de) | 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen | |
| DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| DE60328517D1 (de) | Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung | |
| DE602005012905D1 (de) | Verwendung von Substanz P zur Mobilisierung und Proliferation mesenchymaler Stammzellen und zur Wundheilung | |
| DE602004016385D1 (de) | Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits | |
| DE602004019229D1 (de) | Inhibitoren von mitotischem kinesin | |
| ATE525480T1 (de) | Verwendung von a33-antigenen und jam-it | |
| ATE534649T1 (de) | Imidazothiazole und imidazoxazolderivative als inhibitoren von p38 | |
| DE60335018D1 (de) | Mittel zur verhinderung von hautalterung | |
| ATE455553T1 (de) | Verwendung von hsp20 zur förderung der wundheilung und/oder zur reduzierung der narbenbildung | |
| ATE363531T1 (de) | Claudin polypeptide | |
| ATE472329T1 (de) | Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| ATE557092T1 (de) | Bv8-nukleinsäuren und polypeptide mit mitogener aktivität | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| DE60323533D1 (de) | Methode zur stimulierung von haarwuchs auf der basis von benzopyranen | |
| ATE491442T1 (de) | 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz | |
| BRPI0411168A (pt) | composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos | |
| DE60325496D1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1594526 Country of ref document: EP |